August 31, 2014 5:42 AM ET

Capital Markets

Company Overview of Aisling Capital

Executive Profile

Joshua H. Bilenker M.D.

Founder, Chief Executive Officer, President and Director, Loxo Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships
42--

Background

Dr. Joshua H. Bilenker, MD, also known as Josh, is a Partner and Principal at Aisling Capital. Dr. Bilenker has been the Chief Executive Officer and President of Loxo Oncology, Inc. which he founded May 2013. He served as Chief Financial Officer and Principal Accounting Officer of Loxo Oncology, Inc. Previously, he served as a Medical Officer in the Office of Oncology Drug Products at the United States Food and Drug Administration. While at the FDA, he conducted clinical ...

Corporate Headquarters

888 Seventh Avenue
New York, New York 10106

United States

Phone: 212-651-6380
Fax: 212-651-6379

Board Members Memberships

Director
Director
Director
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2011-Present
Director and Member of Audit Committee
2013-Present
Founder, Chief Executive Officer, President and Director

Education

MD
Johns Hopkins School of Medicine
BA
Princeton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aisling Capital, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.